Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in the Treatment of Covid 19 Pneumonia : Impact on Viral Load and Clinical Outcomes

Merlin Moni, Thushara Madathil, Dipu T Sathyapalan, Veena Menon, Georg Gutjahr, Fabia Edathadathil, Deepthi Sureshkumar, Preetha Prasanna, Soumya Jose, Roshni Jerome, Ajai Krishnan, Indulekha C Pillai, Geetha Kumar, Bipin Nair, Aveek Jayant
doi: https://doi.org/10.1101/2021.04.15.21255300
Merlin Moni
1Department of Medicine, Division of Infectious Diseases, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thushara Madathil
2Department of Cardiac Anaesthesiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
DM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dipu T Sathyapalan
1Department of Medicine, Division of Infectious Diseases, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veena Menon
3Clinical Virology Laboratory, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Gutjahr
4Georg Gutjahr, Centre for Research in Analytics and Technologies for Education (CREATE), Amrita Vishwa Vidyapeetham, Amritapuri, Kollam 690546, Kerala, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabia Edathadathil
5Fabia Edathadathil, Department of Infection Control and Epidemiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepthi Sureshkumar
6School of Medicine, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Preetha Prasanna
1Department of Medicine, Division of Infectious Diseases, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soumya Jose
3Clinical Virology Laboratory, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roshni Jerome
3Clinical Virology Laboratory, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajai Krishnan
3Clinical Virology Laboratory, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Indulekha C Pillai
7School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Kollam 690546, Kerala, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geetha Kumar
7School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Kollam 690546, Kerala, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bipin Nair
8Faculty of Sciences, Amrita Vishwa Vidyapeetham, Amritapuri, Kollam 690546, Kerala, India
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aveek Jayant
1Department of Medicine, Division of Infectious Diseases, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
DM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jayant.aveek@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

SUMMARY

Background Hypoxic patients with Covid 19 pneumonia are at high risk of adverse outcomes. Inhaled Nitric Oxide (iNO) inhibits viral entry and replication of SARS-CoV2 and in vivo proof of its antiviral actions is unavailable to date. This feasibility study was conducted to test the antiviral effects of iNO and to describe clinical outcomes.

Trial design and Methods The phase II open label, randomised controlled feasibility trial(ISRCTN 16806663) conducted at a South Indian tertiary care referral centre, recruited COVID-19 pneumonia patients with hypoxic respiratory failure and allocated them into iNO cases and control groups(1:1). iNO was administered as pulses for 30 minutes for three consecutive days at 12-hour intervals in cases, in addition to standard of care received by the control group. The primary outcome was decline in viral load, as defined by a surrogate change in the RT-PCR cycle threshold. The co-primary clinical outcome was time to improvement of >2 points on the WHO Ordinal Scale(WOS).

Results Among the 29 patients enrolled, 14 iNO cases and 11 controls completed the study protocol. Longitudinal analysis revealed a significant difference in the decline (p <0.002, N= 23) in viral load among the iNO cases compared to controls. The proportion of patients achieving 2-point improvement in the WOS within 14 days of randomisation was significantly higher in the iNO cases (n=11, 79%), as compared to the controls (n=4, 36%) (p=0.05).

Conclusions Our study demonstrated significant improvement in virological and clinical outcomes among patients with adjunct iNO therapy and no adverse effects were reported.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ISRCTN 16806663

Funding Statement

The work was supported by the collaborating centre, the Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Drugs Controller General India Institutional Ethics Committee, Amrita Institute of Medical Science

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 20, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in the Treatment of Covid 19 Pneumonia : Impact on Viral Load and Clinical Outcomes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in the Treatment of Covid 19 Pneumonia : Impact on Viral Load and Clinical Outcomes
Merlin Moni, Thushara Madathil, Dipu T Sathyapalan, Veena Menon, Georg Gutjahr, Fabia Edathadathil, Deepthi Sureshkumar, Preetha Prasanna, Soumya Jose, Roshni Jerome, Ajai Krishnan, Indulekha C Pillai, Geetha Kumar, Bipin Nair, Aveek Jayant
medRxiv 2021.04.15.21255300; doi: https://doi.org/10.1101/2021.04.15.21255300
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in the Treatment of Covid 19 Pneumonia : Impact on Viral Load and Clinical Outcomes
Merlin Moni, Thushara Madathil, Dipu T Sathyapalan, Veena Menon, Georg Gutjahr, Fabia Edathadathil, Deepthi Sureshkumar, Preetha Prasanna, Soumya Jose, Roshni Jerome, Ajai Krishnan, Indulekha C Pillai, Geetha Kumar, Bipin Nair, Aveek Jayant
medRxiv 2021.04.15.21255300; doi: https://doi.org/10.1101/2021.04.15.21255300

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1965)
  • Dentistry and Oral Medicine (253)
  • Dermatology (187)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11124)
  • Forensic Medicine (8)
  • Gastroenterology (630)
  • Genetic and Genomic Medicine (3202)
  • Geriatric Medicine (310)
  • Health Economics (567)
  • Health Informatics (2051)
  • Health Policy (864)
  • Health Systems and Quality Improvement (790)
  • Hematology (310)
  • HIV/AIDS (686)
  • Infectious Diseases (except HIV/AIDS) (12745)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (319)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3004)
  • Nursing (167)
  • Nutrition (466)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1563)
  • Ophthalmology (478)
  • Orthopedics (186)
  • Otolaryngology (266)
  • Pain Medicine (203)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (915)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (356)
  • Psychiatry and Clinical Psychology (2807)
  • Public and Global Health (5616)
  • Radiology and Imaging (1102)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (764)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (290)
  • Surgery (348)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)